3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer

NCT00095888 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

68

Enrollment

NIH

Sponsor class

Stopped Administratively complete.

Conditions

Male Breast Cancer
Recurrent Breast Cancer
Stage IV Breast Cancer

Interventions

DRUG: triapine
DRUG: gemcitabine hydrochloride
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

National Cancer Institute (NCI)